wellrank.ai
Sign In
Effexor logo

Effexor

First cited by AI Jun 11, 2026
effexorvenlafaxine.com

Surfaced organically in AI answers about menopause and women's health. Not yet profiled.

AI Visibility

Visibility trend

Menopause and women's health, daily share of AI answers mentioning Effexor, through Sep 11, 2026.

4.4%

Avg position when mentioned: 5.5 · peak 8% on Jun 11

By engine

Where Effexor is strong, and where it is invisible.

  • ChatGPT
    13.3%

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 28 positive mentions
  • 16 neutral
  • 0 mixed or cautious

Recent AI answers mentioning Effexor

ChatGPTSep 11, 2026, 15:17 UTC
What is the best non hormonal treatment for hot flashes?

Short answer: for most people the most effective non‑hormonal treatments are certain antidepressants (SSRIs/SNRIs — e.g., paroxetine or venlafaxine), gabapentin, and behavioral therapies (CBT). Which is “best” depends on your medical history, other meds (especially tamoxifen), side‑effect tolerance, and whether daytime or nighttime hot flashes are worse. Options to consider (with brand names and why): Paroxetine (Brisdelle®) — FDA‑approved specifically for menopausal hot flashes; effective at low dose. Important: paroxetine can block the action of tamoxifen, so it’s usually avoided in women taking tamoxifen for breast cancer. Side effects can include drowsiness, sexual side effects, and withdrawal if stopped abruptly. Venlafaxine (Effexor®) or desvenlafaxine (Pristiq®) — strong evidence for reducing frequency and severity of hot flashes; often a good alternative when paroxetine is not appropriate. Side effects: nausea, increased blood pressure in some people, nervousness. Gabapentin (Neurontin®) — particularly helpful for nighttime hot flashes and sleep disturbance; often used when antidepressants aren’t tolerated. Side effects: dizziness, sedation, unsteadiness. Clonidine (Catapres®) — modest benefit for some; can be useful if other meds aren’t suitable. Side effects: dry mouth, dizziness, low blood pressure. Oxybutynin (Ditropan®) — evidence for benefit in some studies at low doses; often used off‑label. Side effects are anticholinergic (dry mouth, constipation, urinary retention) and can affect cognition in older adults. Non‑drug and behavioral approaches (often best used together with meds or alone if you prefer no meds): Cognitive behavioral therapy (CBT) for menopausal symptoms — reduces how much hot flashes bother you even if frequency doesn’t fall as much. Recommended by multiple guidelines. If you prefer online options, look for therapists/ programs through menopause telehealth clinics such as Gennev, Evernow, or Maven Clinic (they offer menopause specialists and CBT/coaching). Mindfulness, paced breathing, and relaxation training — small to moderate benefit and no medication side effects. Practical cooling strategies and products —: moisture‑wicking sleepwear/sheets (Cool-jams®, SHEEX®), bed cooling systems (ChiliSleep/ChiliPad®), and a good bedside fan — inexpensive, immediate relief for many people. Lifestyle measures — regular aerobic exercise, stopping smoking, avoiding spicy foods/alcohol/large meals at night, and keeping bedroom cool can reduce triggers. Other options to discuss with your clinician: Stellate ganglion block (procedure) has emerging evidence but is invasive and not standard first line. Herbal supplements (black cohosh, soy/isoflavones) have mixed/variable evidence and quality; discuss with your clinician before trying. How to choose If you want a medication with strong evidence and are not on tamoxifen: paroxetine (Brisdelle) or an SNRI (venlafaxine/desvenlafaxine) are common first choices. If nighttime hot flashes and sleep problems predominate: gabapentin often helps. If you prefer no medication or want to reduce how much hot flashes bother you: CBT/mindfulness plus cooling strategies. If you have breast cancer or take tamoxifen: avoid paroxetine; venlafaxine is often preferred (confirm with your oncologist). Next step Talk with your primary care clinician, gynecologist, or a menopause specialist to pick the best option for your situation and review interactions/side effects. If you’d like, tell me whether you have breast cancer or take tamoxifen, which symptoms bother you most (day vs night), and whether you prefer medication vs non‑drug approaches — I can suggest a more specific plan.

Mentioned in position 2 of 12

Read full answer with sources →
ChatGPTSep 9, 2026, 15:24 UTC
I am 47 with hot flashes and terrible sleep. What are my treatment options?

At 47 with hot flashes and poor sleep you’re most likely in perimenopause/menopause. There are several effective options — lifestyle/behavioral changes, medications (hormonal and non‑hormonal), and sleep‑focused therapies. The right choice depends on your symptoms, medical history, and personal risks (especially any history of breast cancer, blood clots, stroke, liver disease, or uncontrolled heart disease). Talk with your primary care doctor, gynecologist, or a menopause specialist to choose and monitor therapy. Below is a practical overview with specific brands/services you can discuss. 1) Hormone therapy (most effective for hot flashes and often improves sleep) What it is: Systemic estrogen (with a progestin if you still have a uterus) reduces hot flashes and often restores sleep. Routes & example brands: Transdermal patch: Vivelle‑Dot, Climara — steady hormone levels, lower clot vs some oral forms, good if you have nausea or GI issues. Topical gel: Estrogel (estradiol) — flexible dosing. Oral estrogen: Estrace (estradiol), Premarin (conjugated estrogens) — effective but oral estrogen has higher effect on clotting markers. Combined (for women with a uterus): Activella (estradiol + norethindrone), Prempro. Benefits vs risks: Most effective for hot flashes and night sweats, improves sleep. Risks include higher risk of blood clots, stroke (especially starting late), and a small increase in breast cancer risk with long‑term combined therapy. Generally recommended to use the lowest effective dose for the shortest needed time; individualized decision with your clinician. 2) Non‑hormonal medicines (if hormones are not appropriate or preferred) Antidepressants/SNRIs: Low‑dose paroxetine (Brisdelle 7.5 mg) — FDA approved for hot flashes. Important: paroxetine interferes with tamoxifen (if you are taking tamoxifen for breast cancer prevention/treatment, avoid). Venlafaxine (Effexor) and desvenlafaxine — often reduce hot flashes fairly quickly. Gabapentin (Neurontin) — useful for night sweats, taken at night in divided doses. Clonidine (Catapres) — modest benefit for hot flashes, may cause dry mouth, dizziness. For sleep specifically: low‑dose doxepin (Silenor) for sleep maintenance, trazodone commonly used off‑label, or short courses of zolpidem (Ambien) or eszopiclone (Lunesta) for insomnia — discuss dependency and side effects with your clinician. Notes: These meds help hot flashes or sleep but have side effects; choose based on other conditions and interactions. 3) Behavioral and sleep‑focused treatments (first‑line for insomnia) Cognitive Behavioral Therapy for Insomnia (CBT‑I) is a strongly evidence‑based treatment and often more durable than sleeping pills. Online CBT‑I programs: Sleepio and SHUTi have good evidence and are easy options. Ask for a referral to a CBT‑I trained clinician (many psychologists and sleep clinics offer this). Sleep hygiene and habits: cool, dark, consistent sleep schedule; avoid caffeine and alcohol near bedtime; limit evening screen time; keep bedroom cool and layered bedding. Bed/cooling products: consider a bedside fan and cooling mattress/pad such as ChiliSleep (formerly ChiliPad) or Eight Sleep if night sweats make falling/staying asleep hard. 4) Lifestyle & self‑care to reduce hot flashes and improve sleep Avoid triggers (hot drinks, spicy foods, alcohol, caffeine, hot rooms). Dress in layers, moisture‑wicking sleepwear, use a fan. Regular aerobic exercise and weight management can help overall well‑being (effects on hot flashes are variable). Mind‑body practices: mindfulness, paced respiration, and yoga may reduce symptom bother. 5) Complementary therapies (mixed evidence) Soy/isoflavone supplements — small benefit for some women. Black cohosh — mixed evidence and quality control concerns; discuss with clinician. Acupuncture — some women report improvement, evidence is limited. 6) When to see a specialist or pursue testing If hot flashes or insomnia severely impair daily life, or if you have risk factors (breast cancer, history of blood clots, stroke, heart disease), see your clinician for individualized care. If sleepiness, loud snoring, or witnessed apneas occur, consider a sleep clinic evaluation for sleep apnea (which can be worsened in menopause). Your doctor may want baseline screening (mammogram per guidelines) and to discuss cardiovascular and clotting risk before starting hormone therapy. Next steps I recommend Make an appointment with your primary care clinician or gynecologist and discuss: severity of hot flashes and sleep problems, past medical history (breast cancer, clotting disorders, migraines), and current medications (e.g., tamoxifen). If you want a low‑burden start, ask about transdermal estradiol (patch) versus a nonhormonal option like venlafaxine or gabapentin — pros/cons will depend on your medical history. If insomnia is your main issue, ask for CBT‑I referral or try a reputable online CBT‑I program (Sleepio or SHUTi). If helpful, I can draft questions to bring to your clinician or help you compare two specific treatments. If you want, tell me: do you have a history of breast cancer, clotting problems, heart disease, migraines, or are you on tamoxifen or other medications? I can give more specific guidance based on that.

Mentioned in position 9 of 18

Read full answer with sources →
ChatGPTSep 4, 2026, 15:12 UTC
I am 47 with hot flashes and terrible sleep. What are my treatment options?

At 47, hot flashes and poor sleep are commonly part of the menopausal transition (perimenopause/menopause). There are many effective options — lifestyle and behavioral changes, prescription medicines (hormonal and non‑hormonal), and some over‑the‑counter and complementary approaches. Which is best depends on your overall health, medical history (breast cancer, blood clots, heart disease, liver disease), whether you still have a uterus, and how severe your symptoms are. Discuss options with your primary care doctor or a menopause specialist (see NAMS — North American Menopause Society). Brief, practical summary of options 1) Menopausal hormone therapy (most effective for hot flashes and often improves sleep) Systemic estrogen (oral or transdermal) is the most effective treatment for vasomotor symptoms. Transdermal patches/gels are often preferred if you have migraine with aura, clot risk, or trouble with oral estrogens. Common brands: Climara, Vivelle‑Dot, Alora (estradiol patches); Estrace (oral estradiol); EstroGel/Divigel (topical gels). If you have a uterus, you’ll also need progestogen to protect the lining of the uterus. Common options: Prometrium (micronized progesterone), Mirena IUD (levonorgestrel) as a local progestin. Duavee (conjugated estrogens + bazedoxifene) is an option for women who want to avoid a separate progestin. Why: most reliable relief of hot flashes and often improves night sweats and sleep fragmentation. Important: discuss risks/benefits (breast cancer history, clot risk, stroke, timing). Use the lowest effective dose for the shortest time needed and with medical oversight. 2) Non‑hormonal prescription options (if hormones aren’t appropriate or aren’t chosen) Paroxetine 7.5 mg (Brisdelle) — an SSRI FDA‑approved for hot flashes. Avoid if you’re taking tamoxifen. SSRIs/SNRIs (off‑label): venlafaxine (Effexor), escitalopram (Lexapro) — good evidence for hot flashes and may help mood/sleep. Gabapentin (Neurontin) — helpful for nighttime hot flashes; often used as a bedtime dose. Clonidine — modest benefit for some women. Why: these are effective alternatives when hormones are contraindicated or unwanted. 3) Treatments targeted primarily at sleep Cognitive Behavioral Therapy for Insomnia (CBT‑I) — first‑line for chronic insomnia and effective long term. Digital/online programs: Somryst (FDA‑cleared digital CBT‑I), Sleepio (widely used digital CBT‑I). Local therapists: look for clinicians trained in CBT‑I (check your insurer or PsychologyToday). Prescription sleep meds when needed: zolpidem (Ambien), eszopiclone (Lunesta), zaleplon (Sonata), low‑dose doxepin (Silenor) or ramelteon (Rozerem). Use short term and discuss fall/next‑day effects with your clinician. Melatonin (OTC) 0.5–3 mg or timed‑release formulations can help some people; brands: Natrol, Life Extension. Ramelteon is a prescription melatonin receptor agonist. Why: CBT‑I treats the underlying insomnia and has durable benefits; meds can help short term. 4) Lifestyle and sleep hygiene (always recommended) Bedroom: keep cool, use breathable bedding, fan at night. Lower room temperature to reduce night sweats. Avoid hot drinks, spicy foods, alcohol, and nicotine before bed; limit caffeine after early afternoon. Layered clothing you can remove quickly during a hot flash. Regular aerobic exercise and weight management can reduce symptom severity for some women. Sleep hygiene: consistent schedule, limit naps, reduce evening screen time, wind‑down routine. 5) Complementary and OTC approaches (evidence mixed; discuss safety) Soy isoflavones, black cohosh, red clover — results inconsistent; check interactions and quality; avoid if you have hormone‑sensitive cancer unless approved by your oncologist. Cognitive relaxation, mindfulness, and paced respiration may reduce hot flash bother. Vaginal moisturizers/low‑dose vaginal estrogen (Estring, vaginal tablets like Vagifem) help genitourinary symptoms but do not treat hot flashes systemically. Why: some women get meaningful relief, but evidence varies and quality control for supplements is variable. 6) Check for other contributors to poor sleep Sleep apnea, restless legs, mood disorders, pain, or medications can cause sleep problems; if you snore, wake gasping, or feel very sleepy in daytime, get evaluated for sleep apnea. Consider reviewing current meds and alcohol use with your clinician. 7) Specialist referrals and resources See a primary care doctor, gynecologist, or a menopause specialist if symptoms are moderate‑severe or if you want hormone therapy. Resources: North American Menopause Society (NAMS.org) for clinician directories and patient info. CBT‑I digital programs: Somryst (Pear Therapeutics), Sleepio (Big Health) — accessible without in‑person therapy in many areas. Next steps I recommend Book an appointment with your primary care doctor or gynecologist and describe how the hot flashes and sleep are affecting your life. If you want the most effective relief and have no contraindications, ask about systemic hormone therapy (ask specifically about transdermal estradiol if clot risk or side effects are concerns). If hormones aren’t an option, ask about paroxetine (Brisdelle), venlafaxine, or gabapentin for hot flashes and about CBT‑I (Somryst or Sleepio) for sleep. If symptoms are severe or you have risk factors (breast cancer, VTE, heart disease), request referral to a menopause specialist. If you’d like, tell me: whether you still have periods, any major medical history (breast cancer, clotting events, heart disease, migraines), current medications, and I can help you narrow the safest, most likely effective options.

Mentioned in position 11 of 27

Read full answer with sources →
ChatGPTAug 30, 2026, 15:35 UTC
I am 47 with hot flashes and terrible sleep. What are my treatment options?

Short answer: the most effective treatment for hot flashes (and for hot-flash–related sleep disruption) is systemic hormone therapy (estrogen ± a progestogen if you still have a uterus). If hormones aren’t appropriate or you prefer not to use them, several non‑hormonal prescription and behavioral options work well. Which is best for you depends on your health history (breast cancer, blood clots, stroke, smoking, migraine with aura, etc.). See a clinician to choose and monitor therapy. Below are practical options, with brand examples and why they might be used. 1) Lifestyle and behavioral first steps (try these immediately) Sleep hygiene: regular sleep schedule, limit evening caffeine/alcohol, cool bedroom, blackout curtains. Keep a cool sleeping environment and breathable sleepwear to reduce night sweats. Cognitive Behavioral Therapy for Insomnia (CBT‑I) — first-line for chronic insomnia and often improves sleep despite hot flashes. In‑person CBT‑I or digital programs such as Somryst (prescription) or Sleepio can help. Mindfulness/relaxation, paced breathing, and regular exercise (not right before bed). 2) Systemic hormone therapy — most effective for hot flashes and often restores sleep If you do not have contra‑indications, consider: Transdermal estradiol patch or gel (examples: Vivelle‑Dot, Climara, Estraderm, Divigel). Patches/gels: lower VTE risk than oral estrogen for many people. Oral estradiol (Estrace) or conjugated estrogens (Premarin). If you have a uterus you must add a progestogen to prevent endometrial hyperplasia — commonly micronized progesterone (Prometrium) or an inert intrauterine device (Mirena) in some cases. Why: fastest and most reliable relief of vasomotor symptoms and improves sleep. Risks vary with age, time since menopause, and personal risk factors (breast cancer, clotting, stroke). 3) Non‑hormonal prescription options (for people who can’t or prefer not to take hormones) Paroxetine 7.5 mg (Brisdelle) — the only nonhormonal FDA‑approved pill specifically for hot flashes. Note: interacts with tamoxifen; avoid if you’re on tamoxifen. Venlafaxine (Effexor) or desvenlafaxine — SNRIs that reduce hot flashes and can help sleep; often started low (e.g., 37.5 mg) and adjusted. Gabapentin (Neurontin) — particularly helpful for nighttime hot flashes and sleep; usually taken at bedtime (sometimes divided doses). Clonidine (Catapres) — modest benefit for some people; can have side effects like dry mouth and dizziness. Why: useful if hormones are contraindicated (e.g., active or recent breast cancer) or if you prefer nonhormonal therapy. 4) Treatments directed at sleep CBT‑I (above) is the preferred long‑term treatment for insomnia. Short‑term pharmacologic options for sleep maintenance: Low‑dose doxepin (Silenor) for sleep maintenance (prescription). Melatonin (0.5–3 mg) or extended-release melatonin can help circadian regulation for some people. Sedative hypnotics (zolpidem/Ambien, eszopiclone/Lunesta) may be used short‑term with caution (next‑day effects, dependence). If hot flashes are the major cause of awakenings, treating vasomotor symptoms often restores sleep. 5) Local vaginal symptoms (if present) Low‑dose vaginal estrogen (Estring ring, Vagifem tablets, Estrace cream) improves vaginal dryness and sexual symptoms with minimal systemic exposure. 6) Complementary/alternative options (evidence mixed) Soy isoflavones and black cohosh have inconsistent evidence; talk to your clinician before trying supplements. Acupuncture has mixed results; some people find benefit. Important safety/selection notes Hormone therapy is usually safest and most beneficial when started for symptomatic women younger than ~60 or within 10 years of menopause; risks and benefits should be individualized. If you have a history of breast cancer, active liver disease, prior venous thromboembolism, stroke, or uncontrolled cardiovascular disease, systemic hormones may not be appropriate. If you are on tamoxifen, avoid paroxetine and other strong CYP2D6 inhibitors (they reduce tamoxifen’s effectiveness). Discuss progestogen choice (micronized progesterone may have a different risk profile than synthetic progestins). What to do next See your primary care doctor, gynecologist, or a menopause specialist. Tell them about your hot flash frequency, severity, and how sleep is affected. Share any relevant history (breast cancer, blood clots, migraines with aura, smoking). The clinician may review risks, consider basic labs as needed, and discuss whether systemic hormone therapy is appropriate or recommend a specific nonhormonal drug or CBT‑I. If you want, I can help you: (a) prepare questions for your clinician, (b) compare specific hormone options and likely side effects for your situation, or (c) find CBT‑I/digital programs or local clinicians. Would you like to share any medical history (breast cancer, clotting disorder, medications, smoking) or preferences about hormones?

Mentioned in position 12 of 19

Read full answer with sources →
ClaudeAug 30, 2026, 15:35 UTC
I am 47 with hot flashes and terrible sleep. What are my treatment options?

Treatment Options for Hot Flashes & Sleep Issues at 47 You're likely in perimenopause, and there are good options across different approaches: Medical Treatments (Most Effective) Hormone Therapy (HRT/MHT) Brands: Vivelle-Dot (patch), Estrace (cream), Bijuva (oral) Most effective option for hot flashes and sleep Talk to your OB-GYN or a menopause specialist Non-Hormonal Prescriptions Veozah (fezolinetant) - FDA-approved specifically for hot flashes Effexor (venlafaxine) - antidepressant that helps hot flashes Gabapentin - also helps with sleep Telehealth Options (Convenient) Midi Health - menopause specialist platform Alloy - online menopause care Evernow - hormone therapy via telehealth Supplements (Moderate Evidence) Remifemin (black cohosh) Relizen (pollen extract) Magnesium Glycinate for sleep Lifestyle Support Oura Ring to track sleep patterns Calm or Sleepio apps for sleep CBT I'd strongly recommend starting with a doctor consultation — ideally one certified by the Menopause Society (NAMS). Would you like more detail on any option?

Mentioned in position 5 of 14

Read full answer with sources →
ChatGPTAug 23, 2026, 11:52 UTC
How do I know if I am in perimenopause?

Short answer: you may be in perimenopause if your periods and/or typical symptoms are changing. Perimenopause is the transition before menopause (the year after your last period) when ovarian hormone production becomes irregular. It commonly starts in your 40s but can begin earlier. What to watch for Menstrual changes: cycles shorter or longer, missed periods, heavier or lighter bleeding. Vasomotor symptoms: hot flashes and night sweats. Sleep problems and fatigue. Mood changes: irritability, anxiety, low mood. Vaginal dryness, painful sex, urinary urgency or infections. Decreased libido, brain fog, memory/ concentration trouble, joint aches. How it’s diagnosed Clinical diagnosis is usually based on symptoms and menstrual pattern. Menopause is confirmed after 12 consecutive months without a period. Blood tests can help rule out other causes: pregnancy test if relevant, TSH (thyroid), CBC if heavy bleeding, and sometimes FSH and estradiol. FSH can fluctuate during perimenopause, so a single value is often inconclusive. Anti-Müllerian Hormone (AMH) may give information but is not routinely required. If you have new heavy bleeding, very irregular bleeding, or bleeding after sex, you should be evaluated for other causes (polyps, fibroids, infection, cancer). When to see a clinician right away Very heavy bleeding (soaking a pad/hour or passing large clots), fainting, or severe abdominal pain. New, severe symptoms that interfere with daily life (sleep loss, depression, frequent urinary problems). You’re under 40 with irregular periods — see a doctor to check for premature ovarian insufficiency. Treatment and management (brief) Lifestyle: sleep hygiene, layered clothing for hot flashes, regular exercise, limit alcohol/caffeine/smoking, weight-bearing exercise for bone health. Track symptoms with apps like Clue or Flo to show your clinician patterns. Hormone therapy (most effective for hot flashes and vaginal symptoms): options include transdermal estradiol patches (Vivelle-Dot, Climara) or oral estradiol (Estrace, Premarin in some formulations). To protect the uterus, combined therapy or a progestogen is needed if you still have a uterus — oral micronized progesterone (Prometrium) or a levonorgestrel IUD (Mirena) are commonly used. HRT has benefits and risks; it’s individualized, so discuss with your clinician. Nonhormonal meds for hot flashes: low-dose paroxetine (Brisdelle; note it interacts with tamoxifen), venlafaxine (Effexor), or gabapentin (Neurontin). Vaginal dryness: local vaginal estrogen (Estrace cream or prescription vaginal rings/ tablets) or nonhormonal lubricants/moisturizers. Bone health: calcium/vitamin D (brands like Nature Made/Caltrate) and, if indicated, prescription therapies such as alendronate (Fosamax) or denosumab (Prolia). If contraception is still needed: many contraceptives are used in perimenopause; discuss with your clinician. Practical next steps Track your periods and symptoms for 2–3 months (dates, flow, hot flashes, sleep, mood). Make an appointment with your primary care doctor or gynecologist; mention you suspect perimenopause. If you want specialized care, look for a menopause specialist or resources at the North American Menopause Society (NAMS). Ask which tests are appropriate for you (pregnancy test if relevant, TSH, CBC, possibly FSH/estradiol). Discuss treatment goals (relief of hot flashes, sleep, sexual symptoms, contraception) and safe options for your medical history. If you’d like, tell me your age, menstrual changes you’re seeing, and any medical history (blood clots, breast cancer, current meds, whether pregnancy is possible). I can help suggest the most likely next steps and which treatments might fit your situation.

Mentioned in position 10 of 16

Read full answer with sources →

TL;DR

Effexor (venlafaxine) is a prescription serotonin-norepinephrine reuptake inhibitor (SNRI) manufactured by Pfizer and widely used off-label to manage vasomotor symptoms such as hot flashes in menopausal women who cannot or prefer not to use hormone therapy. Its official patient resource site lives at effexorvenlafaxine.com. In WellRank's latest index it ranks 12th in the Menopause and women's health category with 8% AI visibility, appearing in AI answers alongside non-hormonal alternatives like Veozah and Brisdelle.

Company Overview

Effexor is a brand-name prescription antidepressant originally developed by Wyeth and now marketed by Pfizer following Pfizer's acquisition of Wyeth in 2009. The drug itself is a small-molecule SNRI available in immediate-release and extended-release formulations, with the extended-release version sold as Effexor XR. Pfizer operates as a publicly traded global pharmaceutical company; the effexorvenlafaxine.com site functions as a patient and prescriber information resource rather than a direct-to-consumer sales channel.

Product Features

  • Effexor XR (venlafaxine extended-release capsules) for once-daily dosing
  • Immediate-release venlafaxine tablets as a generic-available alternative
  • FDA-approved treatment for major depressive disorder, generalized anxiety disorder, social anxiety disorder, and panic disorder
  • Widely used off-label for reduction of menopausal hot flashes and night sweats
  • Studied as a non-hormonal option for breast cancer survivors managing vasomotor symptoms

Target Market

Effexor is prescribed primarily in the United States and other markets where Pfizer operates, serving adults with mood and anxiety disorders as its core FDA-approved population. A significant and growing segment of its real-world use covers perimenopausal and postmenopausal women seeking non-hormonal relief from vasomotor symptoms, particularly those with contraindications to estrogen-based therapies. Resources such as womenshealth.gov's menopause treatment guidance and Harvard Health's overview of nonhormonal menopause treatments frequently mention venlafaxine in this context.

Buyer Personas

  • A perimenopausal woman in her late 40s or early 50s who experiences frequent hot flashes and prefers a non-hormonal prescription option recommended by her OB-GYN.
  • A breast cancer survivor whose oncologist has advised against hormone therapy and who is looking for evidence-based vasomotor symptom relief, as discussed in resources like Facing Our Risk's menopause management guide.
  • An adult patient already managing depression or anxiety who receives added benefit from venlafaxine for concurrent menopausal symptoms.
  • A primary care physician or gynecologist researching off-label prescribing options for patients who are not candidates for FDA-approved hormone replacement therapies.

Funding & Performance

Effexor is a product of Pfizer, a publicly traded company (NYSE: PFE). Revenue figures specific to Effexor or venlafaxine are not broken out separately in Pfizer's public filings; the branded Effexor XR lost patent exclusivity years ago and generic venlafaxine now dominates the market. Brand-level sales figures are not publicly disclosed.

Recent Developments

Clinical and regulatory attention around non-hormonal menopause treatments has intensified following the FDA approval of fezolinetant (Veozah) in 2023, which has renewed interest in comparing all available non-estrogen options including venlafaxine. Peer-reviewed research indexed in sources like PubMed Central and ScienceDirect continues to examine venlafaxine's efficacy for vasomotor symptoms relative to newer entrants. Telehealth platforms specializing in women's health, such as Midi Health, have incorporated venlafaxine into their non-hormonal treatment discussions, increasing its digital visibility.

Competitive Landscape

In WellRank's co-mention data, Effexor most frequently appears alongside Veozah (fezolinetant, the first FDA-approved non-hormonal NK3 receptor antagonist for hot flashes), Brisdelle (the only FDA-approved paroxetine formulation for vasomotor symptoms), and Wellbutrin (another non-SNRI antidepressant sometimes considered off-label). Hormone-based options like Vivelle-Dot also appear in the same AI answer sets, reflecting the broader trade-off framing clinicians and patients encounter. Sleep-focused brands Sleepio, Silenor, and Rozerem round out the co-mention set, suggesting AI engines frequently discuss Effexor in threads that cover the full spectrum of menopause-related sleep and mood disruption. The Cleveland Clinic's podcast on managing menopause without hormones illustrates the clinical framing in which these options are compared.

Effexor vs the brands AI recommends alongside it

The real competitive set in Menopause and women's health: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
Effexor logo
EffexorThis brand
#72
4.4%
Brisdelle logo
Brisdelle

39 shared answers

#17
11.1%
Neurontin logo
Neurontin

28 shared answers

#43
6.7%
Vivelle-Dot logo
Vivelle-Dot

26 shared answers

#4
22.2%
Estrace logo
Estrace

25 shared answers

#5
20.0%

Email me when overtakes Effexor

One email the day the ranks flip. Nothing else.

User Sentiment

Of the three AI-engine mentions tracked in WellRank's current corpus, two carry a positive tone and one is neutral, with no mixed or cautious mentions recorded. This aligns with the generally favorable clinical literature on venlafaxine's efficacy for vasomotor symptoms, tempered by standard prescriber notes about side effects common to SNRIs. Public sentiment in patient communities tends to reflect satisfaction among women who achieve hot-flash relief, alongside typical concerns about discontinuation syndrome that are well-documented in the medical literature.

Pricing

As a generic-dominant medication, venlafaxine is available at prices that vary widely depending on insurance coverage, pharmacy, and formulation. Branded Effexor XR carries a higher list price than generic venlafaxine; exact figures fluctuate and are not published in a stable, citable form. Patients with insurance typically pay a copay; cash prices for generics are substantially lower and vary by retailer.

Sources cited around Effexor

The sites engines cite in answers mentioning this brand. Win these, win the answer.

Track Effexor weekly

One email a week: rank moves, new competitors, and the answers that changed. No noise.

Work at Effexor? Get your AI Visibility Audit.

See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.